Michael R. Megna - CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Issuer Symbol
KNSA on Nasdaq
All Insider Reports
All Insider Reports

Michael R. Megna - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Michael R. Megna for Kiniksa Pharmaceuticals International, plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 27,046 $1,063,178 $39.31 20 Oct 2025 Direct
Performance Share Option 5,456 01 May 2025 Direct Class A Ordinary Share
Performance Share Unit 3,433 01 May 2025 Direct Class A Ordinary Share
Restricted Share Unit 0 04 Oct 2025 Direct Class A Ordinary Share
Share Option 0 20 Oct 2025 Direct Class A Ordinary Share

Transactions reported by Michael R. Megna for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.